Recently Launched!
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Note: Free to use

[GILD] Gilead Sciences, Inc. - EBITDA / Share

Data updated 2024-Mar-24 (Sunday)
  Note: Detailed Statistics for EBITDA / Share in Income Statement for Gilead Sciences, Inc. [NASDAQ:GILD] with frequency distribution chart that analyze trends & history . EBITDA per share is a valuation metric calculated as EBITDA / Shares Outstanding. View Income Statement for broader context

Share       
 
        
 Select stock symbol (if different) and line item / metric for Statement type above & click View to see details
Quarterly EBITDA / Share values for Gilead Sciences, Inc. are rounded to enhance readability
   2023-Dec  2023-Sep  2023-Jun  2023-Mar  2022-Dec  2022-Sep
EBITDA / Share 2.5 2.69 2.05 2.22 2.61 2.96
Sequential Quarter Growth -7.1% +31.2% -7.7% -14.9% -11.8% +31.6%
Quarter-on Quarter Growth -4.2% -9.1% -8.9% -17.8% +65.2% -14.2%
Annual EBITDA / Share values for Gilead Sciences, Inc. are rounded to enhance readability
   2023-Dec  2022-Dec  2022-Jan  2021-Jan  2020-Jan  2019-Jan
EBITDA / Share 9.3 10.2 7.49 9.71 9.44 4.98
Year-on-Year Growth -8.7% +36.0% -22.9% +2.9% +89.6% -38.2%
2-yr CAGR +11.4% +2.4% -10.9% +39.6% +8.2% -40.6%
3-yr CAGR -1.4% +2.6% +14.6% +6.4% -12.5% -30.3%
4-yr CAGR -0.4% +19.6% -1.8% -8.9% -10.5% -14.4%
5-yr CAGR +13.3% +4.8% -11.9% -7.9% +0.4% +13.4%
Frequency distribution of quarterly EBITDA / Share values from 2008-Jun-30 grouped into buckets. Latest EBITDA / Share value is 2.5 as of 2023-Dec-31

Subsequent stock performance post earnings date till next announcement for Gilead Sciences, Inc. mapped with quarterly EBITDA / Share values reported at that time. Most recent value denoted with star


   
     
Select frequency and calculation type for EBITDA / Share above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for Gilead Sciences, Inc. with subsequent post-earnings performance given EBITDA / Share values. Analysis uses quarterly data and subsequent absolute performance. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
   Underperform (absolute perf.)  Outperform (absolute perf.)
EBITDA / Share - Low 35% 65%
EBITDA / Share - Medium 52% 48%
EBITDA / Share - High 55% 45%
 
EBITDA / Share (Sequential growth %) - Low 52% 48%
EBITDA / Share (Sequential growth %) - Medium 45% 55%
EBITDA / Share (Sequential growth %) - High 50% 50%
 
EBITDA / Share (QoQ growth %) - Low 55% 45%
EBITDA / Share (QoQ growth %) - Medium 37% 63%
EBITDA / Share (QoQ growth %) - High 58% 42%
 

Related to Gilead Sciences, Inc.

Information for Gilead Sciences, Inc.
  : Recent daily/monthly performance & benchmark comparison
  : Historical performance & related information using Time Machine
  : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
  : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
  : Investigate unusual recent performance & technicals with historical context using AI
  : Seasonal performance by calendar months
  : History of Dividend Yield
  : Popular Technical indicator trends (RSI, MACD etc.)
  : Contextualizing recent performance & technical levels into historical decile buckets
  : Dollar Cost Average (DCA) over time in your portfolio
  : Key Simple & Exponential Moving Averages
  : Insights from closest historical matches to recent performance using Artificial Intelligence
  : Insights from similar historical charts to recent chart using Artificial Intelligence
  News Stories : News stories on 2025-May-30 on Google
  SEC Reports : Quarterly reports around 2025-May-30 on SEC Edgar

Compare Gilead Sciences, Inc. with other assets
  : Recent performance across covered assets
  : Prior & Subsequent performance across assets on a historical date
  : Technical indicator levels across covered assets
  : Seasonal performance by calendar months across covered assets
  : Performance Correlations with other assets
  : Volatility relative to the broad market
  : Visually compare/benchmark performance with other assets over time
  : Contrast with other assets over time in a side-by-side presentation
  : Health Care sector performance which includes Gilead Sciences, Inc.
  : Biotechnology industry performance which includes Gilead Sciences, Inc.
Analyze Gilead Sciences, Inc. in multiple dimensions using above resources. Other comparable assets include other stocks/etfs/crypto etc.